The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Open accessAbstract
Background & aims Norfloxacin is highly effective in preventing spontaneous bacterial peritonitis recurrence in cirrhosis, but its role in the primary prevention of this complication is uncertain.Methods Patients with cirrhosis and low protein ascitic levels (<15 g/L) with advanced liver failure (Child-Pugh score > or = 9 points with serum bilirubin level > or = 3 mg/dL) or impaired renal function (serum creatinine level > or = 1.2 mg/dL, blood urea nitrogen level > or = 25 mg/dL, or serum sodium level < or = 130 mEq/L) were included in a randomized controlled trial aimed at comparing norfloxacin (35 patients) vs placebo (33 patients) in the primary prophylaxis of spontaneous bacterial peritonitis. The main end points of the trial were 3-month and 1-year probability of survival. Secondary end points were 1-year probability of development of spontaneous bacterial peritonitis and hepatorenal syndrome.Results Norfloxacin administration reduced the 1-year probability of developing spontaneous bacterial peritonitis (7% vs 61%, P < .001) and hepatorenal syndrome (28% vs 41%, P = .02), and improved the 3-month (94% vs 62%, P = .003) and the 1-year (60% vs 48%, P = .05) probability of survival compared with placebo.Conclusions Primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis. It reduces the incidence of spontaneous bacterial peritonitis, delays the development of hepatorenal syndrome, and improves survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to norfloxacin, rifaximin has been noted to increased survival in patients with advanced liver cirrhosis in several small-scale trials92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Moreover, several small-scale clinical studies have suggested that antibiotics such as norfloxacin and rifaximin increase survival in patients with liver cirrhosis92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
Arroyo, V., Ginès, P., Gerbes, A. L., Dudley, F. J., Geñtilini, P., Laffi, G., Reynolds, T. B., Ring‐Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,694
Self-citationSort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruíz-del-Árbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410603 · Cited by 1,636
Self-citationDiagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Rimola, A., García–Tsao, G., Navasa, M., Piddock, L. J. V., Planas, R., Bernard‐Chabert, B., & Inadomi, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80201-9 · Cited by 1,058
Self-citationFernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Self-citationIncidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginés, À., Escorsell, À., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 874
Self-citationGinés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Self-citationFollo, A., Llovet, J. M., Navasa, M., Planas, R., Forns, X., Francitorra, A., Rimola, A., Gassull, M. A., Arroyo, V., & Rodés, J. (1994) · Hepatology · doi:10.1002/hep.1840200619 · Cited by 597
Self-citationCirculatory function and hepatorenal syndrome in cirrhosis†
Ruíz-del-Árbol, L., Monescillo, A., Arocena, C., Valer, P., Ginès, P., Moreira, V., Milicua, J. M., Jiménez, W., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20766 · Cited by 584
Self-citationRuíz-del-Árbol, L., Urmán, J., Fernández, J., González, M., Navasa, M., Monescillo, A., Albillos, A., Jiménez, W., & Arroyo, V. (2003) · Hepatology · doi:10.1053/jhep.2003.50447 · Cited by 496
Self-citationLlach, J., Ginès, P., Arroyo, V., Rimola, A., Titó, L., Badalamenti, S., Jiménez, W., Gaya, J., Rivera, F., & Rodés, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90441-6 · Cited by 457
Self-citation
Flagged first, then by citations
2 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 709
Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome
Bucsics, T., & Krones, E. (2017) · Gastroenterology report · doi:10.1093/gastro/gox009 · Cited by 108
Guevara, M., Baccaro, M. E., Ríos, J., Martín–Llahí, M., Úriz, J. I., Arbol, L. R. D., Planas, R., Monescillo, A., Guarner, C., Crespo, J., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02293.x · Cited by 107
Self-citationCholongitas, Ε., Calvaruso, V., Senzolo, M., Patch, D., Shaw, S., O’Beirne, J. P., & Burroughs, A. K. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05908.x · Cited by 108
Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality
Cholongitas, Ε., Senzolo, M., Patch, D., Shaw, S., O’Beirne, J. P., & Burroughs, A. K. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328308bb9c · Cited by 108
Elfert, A., Abo Ali, L., Soliman, S., Ibrahim, S., & Abd-Elsalam, S. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000724 · Cited by 105
Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
Simbrunner, B., Trauner, M., & Reiberger, T. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16602 · Cited by 108
Gerbes, A. L., Labenz, J., Appenrodt, B., Dollinger, M. M., Gundling, F., Gülberg, V., Holstege, A., Lynen-Jansen, P., Steib, C. J., Trebicka, J., et al. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0873-4658 · Cited by 102
The multifactorial mechanisms of bacterial infection in decompensated cirrhosis
der Merwe, V., Chokshi, S., Bernsmeier, C., & Albillos, A. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.029 · Cited by 102
Montoliu, S., Ballesté, B., Planas, R., Álvarez, M. A., Rivera, M., Miquel, M., Masnou, H., Cirera, I., Morillas, R. M., Coll, S., et al. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.03.029 · Cited by 100
Self-citationSaab, S., Hernandez, J. C., Chi, A. C., & Tong, M. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.3 · Cited by 99
Recent advances in our understanding of hepatorenal syndrome
Wong, F. S.-H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.96 · Cited by 99
Diagnosis and therapy of ascites in liver cirrhosis
Biecker, E. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i10.1237 · Cited by 99
Neutrophil‐to‐lymphocyte ratio predicts mortality in patients listed for liver transplantation
Leithead, J., Rajoriya, N., Gunson, B. K., & Ferguson, J. (2014) · Liver International · doi:10.1111/liv.12688 · Cited by 95
Piano, S. S., Bunchorntavakul, C., Marciano, S., & Reddy, K. R. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00078-5 · Cited by 95
Microbiota-driven mechanisms at different stages of cancer development
Ivleva, E., & Grivennikov, S. I. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100829 · Cited by 99
Fluid retention in cirrhosis: pathophysiology and management
Kashani, A., Landaverde, C. E., Medici, V., & Rossaro, L. (2008) · QJM · doi:10.1093/qjmed/hcm121 · Cited by 93
Hanouneh, M. A., Hanouneh, I. A., Hashash, J. G., Law, R. J., Esfeh, J. M., López, R., Hazratjee, N., Smith, T. H., & Zein, N. N. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182506dbb · Cited by 95
Management of ascites and hepatorenal syndrome
Piano, S. S., Tonon, M., & Angeli, P. (2017) · Hepatology International · doi:10.1007/s12072-017-9815-0 · Cited by 93
Renal dysfunction in cirrhosis is not just a vasomotor nephropathy
Adebayo, D., Morabito, V., Davenport, A., & Jalan, R. (2014) · Kidney International · doi:10.1038/ki.2014.338 · Cited by 89
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
Durand, F., Graupera, I., Ginès, P., Olson, J. C., & Nadim, M. K. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.09.013 · Cited by 86
Self-citationEpidemiology, Pathophysiology, and Management of Hepatorenal Syndrome
Amin, A. A., Alabsawy, E. I., Jalan, R., & Davenport, A. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.10.002 · Cited by 90
Management of Adult Patients with Ascites Due to Cirrhosis
Runyon, B. A. (2009) · Hepatology · doi:10.1002/hep.23261 · Cited by 83
Management of cirrhotic ascites
Pedersen, J. S., Bendtsen, F., & Møller, S. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315580069 · Cited by 80
Kidneys in chronic liver diseases
Hartleb, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i24.3035 · Cited by 80
Management of patients with cirrhosis awaiting liver transplantation
Cárdenas, A., & Ginès, P. (2010) · Gut · doi:10.1136/gut.2009.179937 · Cited by 81
Self-citationNovel perspectives in the management of decompensated cirrhosis
Bernardi, M., & Caraceni, P. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0045-2 · Cited by 81
Acute kidney injury and hepatorenal syndrome in cirrhosis
Gupta, K., Bhurwal, A., Law, C., Ventre, S., Minacapelli, C. D., Kabaria, S., Li, Y., Tait, C., Catalano, C., & Rustgi, V. K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.3984 · Cited by 84
Twardowska, A., Makaro, A., Binienda, A., Fichna, J., & Sałaga, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063204 · Cited by 84
Kang, Y., Cai, Y., & Yang, Y. X. (2021) · Liver Cancer · doi:10.1159/000521358 · Cited by 78
Oral probiotic VSL #3 attenuates the circulatory disturbances of patients with cirrhosis and ascites
Rincón, D., Vaquero, J., Hernando, A., Galindo, E., Ripoll, C., Puerto, M., Salcedo, M., Francés, R., Matilla, A. M., Catalina, M., et al. (2014) · Liver International · doi:10.1111/liv.12539 · Cited by 76
Self-citationKimer, N., Pedersen, J. S., Busk, T. M., Gluud, L. L., Hobolth, L., Krag, A. A., Møller, S., Bendtsen, F., & Copenhagen Rifaximin (CoRif) Study Group (2016) · Hepatology · doi:10.1002/hep.28898 · Cited by 78
Diagnosis and management of bacterial infections in decompensated cirrhosis
Pleguezuelo, M. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i1.16 · Cited by 72
Angeli, P., Sanyal, A. J., Møller, S., Alessandria, C., Gadano, A. C., Kim, W. R., Sarin, S. K., & Bernardi, M. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02807.x · Cited by 72
Management of hepatorenal syndrome in patients with cirrhosis
Arroyo, V., & Fernández, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.96 · Cited by 72
Self-citationHepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis
Fagundes, C., & Ginès, P. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.12.032 · Cited by 72
Self-citationCurrent concepts in the pathophysiology and management of hepatic encephalopathy.
Frederick, R. T. (2011) · Europe PMC (PubMed Central) · Cited by 72
Changes in the epidemiology and management of bacterial infections in cirrhosis
Piano, S. S., Tonon, M., & Angeli, P. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0329 · Cited by 69
Role of Albumin Treatment in Patients With Spontaneous Bacterial Peritonitis
Poca, M., Concepción, M., Casas, M., Álvarez–Urturi, C., Gordillo, J., Hernández–Gea, V., Román, E. M., Guarner, C., Gich, I. J., Soriano, G., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.11.012 · Cited by 70
Self-citationMandorfer, M., Aigner, E. S., Cejna, M., Ferlitsch, A., Datz, C., Gräter, T., Graziadei, I. W., Gschwantler, M., Hametner‐Schreil, S., Hofer, H., et al. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02229-w · Cited by 69
Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver
Lutz, P. L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.304 · Cited by 67
Acute-on-Chronic Liver Failure
Asrani, S. K., Simonetto, D. A., & Kamath, P. S. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.008 · Cited by 71
Ekpanyapong, S., & Reddy, K. R. (2019) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-019-00229-2 · Cited by 70
Gifford, F. J., Morling, J. R., & Fallowfield, J. A. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13912 · Cited by 67
Loomba, R. S., WESLEY, R. A., Bain, A. J., Csákó, G., & Pucino, F. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.12.018 · Cited by 66
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
(2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.1005 · Cited by 65
Muñoz, L., Borrero, M. J., Cantera, M., Lario, M., Díaz, D., Francés, R., Monserrat, J., Pastor, Ó., Aguado-Fraile, E., Such, J. M., et al. (2012) · Hepatology · doi:10.1002/hep.25854 · Cited by 64
Self-citationSaif, R. U., Dar, H. A., Sofi, S. M., Andrabi, M. S., Javid, G., & Zargar, S. A. (2018) · Indian Journal of Gastroenterology · doi:10.1007/s12664-018-0876-3 · Cited by 64
Dong, T. S., Aronsohn, A. I., Reddy, K. G., & Te, H. S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4313-0 · Cited by 65
Snowdon, V., Lachlan, N. J., Hoy, A. M., Hadoke, P. W. F., Semple, S. I. K., Patel, D., Mungall, W., Kendall, T. J., Thomson, A. J. W., Lennen, R. J., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002248 · Cited by 64
Hepatorenal syndrome: Update on diagnosis and therapy
Acevedo, J., & Cramp, M. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i6.293 · Cited by 62
Komolafe, O., Roberts, D. A., Freeman, S. C., Wilson, P., Sutton, A. J., Cooper, N. J., Pavlov, C. S., Milne, E., Hawkins, N., Cowlin, M., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013125.pub2 · Cited by 64
O’Leary, J. G., Levitsky, J., Wong, F. S.-H., Nadim, M. K., Charlton, M., & Kim, W. R. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13790 · Cited by 61
Acute kidney injury and hepatorenal syndrome in cirrhosis
Israelsen, M. E., Gluud, L., & Krag, A. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12709 · Cited by 72
Assem, M., Elsabaawy, M., Abdelrashed, M., El-Emam, S. M., Khodeer, S. A., Hamed, W., Abdelaziz, A., & El-Azab, G. (2015) · Hepatology International · doi:10.1007/s12072-015-9688-z · Cited by 60
Fernández, J., Acevedo, J., Prado, V., Mercado, M. S., Castro, M., Pavesi, M., Arteaga, M., Sastre, L., Juanola, A., Ginès, P., et al. (2016) · Liver International · doi:10.1111/liv.13239 · Cited by 58
Self-citationComparison of four model for end-stage liver disease–based prognostic systems for cirrhosis
Huo, T., Lin, H., Huo, S. C., Lee, P.-C., Wu, J., Lee, F., Hou, M., & Lee, S. (2008) · Liver Transplantation · doi:10.1002/lt.21439 · Cited by 58
Management of hepatorenal syndrome
Dündar, H. Z. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i2.277 · Cited by 57
Macnaughtan, J., Figorilli, F., García, E., Lu, H., Jones, H., Sawhney, R., Suzuki, K., Fairclough, S. J., Marsden, J. T., Moratalla, A., et al. (2020) · Nutrients · doi:10.3390/nu12061651 · Cited by 60
Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure
Trebicka, J., Reiberger, T., & Laleman, W. (2018) · Visceral Medicine · doi:10.1159/000490262 · Cited by 58
Caraceni, P., Abraldeṣ, J. G., Ginès, P., Newsome, P. N., & Sarin, S. K. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.024 · Cited by 56
Self-citationPresence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?
Papp, M., Norman, G. L., Vitális, Z., Tornai, I., Altorjay, I., Földi, I., Udvardy, M., Shums, Z., Dinya, T., Orosz, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012957 · Cited by 55
Çekın, Y., Çekın, A. H., Duman, A., Yılmaz, Ü., Yeşil, B., & Yolcular, B. O. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.6014 · Cited by 55
Management of uninfected and infected ascites in cirrhosis
Solà, E., Solé, C., & Ginès, P. (2016) · Liver International · doi:10.1111/liv.13015 · Cited by 53
Self-citationManagement of hepatorenal syndrome in liver cirrhosis: a recent update
Bera, C., & Wong, F. S.-H. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221102679 · Cited by 55
Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis
Soriano, G., Esparcia, Ó., Montemayor, M., Guarner, C., Pericas, R., Torras, X., Calvo, N., Román, E. M., Navarro, F., Guarner, C., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04506.x · Cited by 53
Self-citationAscites: Pathogenesis and therapeutic principles
Møller, S., Henriksen, J. H., & Bendtsen, F. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902912555 · Cited by 53
Multi-resistant bacteria in spontaneous bacterial peritonitis: A new step in management?
de Mattos, Â. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14079 · Cited by 56
Gurung, P., Goldblatt, M. R., Huggins, J. T., Doelken, P., Nietert, P. J., & Sahn, S. A. (2011) · CHEST Journal · doi:10.1378/chest.10-2134 · Cited by 53
Managing portal hypertension in patients with liver cirrhosis
Sauerbruch, T., Schierwagen, R., & Trebicka, J. (2018) · F1000Research · doi:10.12688/f1000research.13943.1 · Cited by 52
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 51
Management of infections in cirrhotic patients: Report of a Consensus Conference
FAGIUOLI, S., Colli, A., Bruno, R., Burra, P., Craxı̀, A., Gaeta, G. B., Grossi, P., Mondelli, M. U., Puoti, M., Sagnelli, E., et al. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.07.015 · Cited by 50
Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis
de Mattos, Â. A., Wiltgen, D., Jotz, R. D. F., Dornelles, C. M. R., Fernandes, M. V., & de Mattos, Â. Z. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.04.010 · Cited by 51
Kulkarni, A. V., Tirumalle, S., Premkumar, M., Kumar, K., Fatima, S. S., Rapole, B., Simhadri, V., Gora, B. A., Sasikala, M., Gujjarlapudi, D., et al. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001611 · Cited by 51
Intestinal permeability in a patient with liver cirrhosis
Aguirre-Valádez, J., Rivera-Espinosa, L., Méndez-Guerrero, O., Chávez-Pacheco, J. L., Juárez, I. G., & Torre, A. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s115902 · Cited by 52
Bacterial Infections in Acute-on-Chronic Liver Failure
Yang, L., Wu, T., Li, J., & Li, . (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1657751 · Cited by 49
Terlipressin in hepatorenal syndrome: Evidence for present indications
Rajekar, H., & Chawla, Y. K. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06583.x · Cited by 48
Surgery in the Patient with Liver Disease
Muilenburg, D. J., Singh, A., Torzilli, G., & Khatri, V. P. (2009) · Anesthesiology Clinics · doi:10.1016/j.anclin.2009.09.007 · Cited by 48
Sepsis-induced acute kidney injury in patients with cirrhosis
Angeli, P., Tonon, M., Pilutti, C., Morando, F., & Piano, S. S. (2015) · Hepatology International · doi:10.1007/s12072-015-9641-1 · Cited by 48
Renal Failure in Patients with Cirrhosis
Mackelaite, L., Alsauskas, Z. C., & Ranganna, K. M. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.03.003 · Cited by 48
Jiménez, C., Cots, M. V., Sala, M., Calafat, M., Garcı́a-Retortillo, M., Cirera, I., Cañete, N., Soriano, G., Poca, M., Simón‐Talero, M., et al. (2022) · Liver International · doi:10.1111/liv.15207 · Cited by 49
Self-citationAsia–Pacific association for study of liver guidelines on management of ascites in liver disease
Singh, V., De, A., Mehtani, R., Angeli, P., Maiwall, R., Satapathy, S. K., Singal, A. K., Saraya, A., Sharma, B. C., Eapen, C. E., et al. (2023) · Hepatology International · doi:10.1007/s12072-023-10536-7 · Cited by 50
Zapater, P., Caño, R., Llanos, L., Ruiz‐Alcaraz, A. J., Pascual, S., Barquero, C., Moreu, R., Bellot, P., Horga, J. F., Muñoz, C., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.058 · Cited by 47
Self-citationThe impact of bacterial infections on survival of patients with decompensated cirrhosis
Strauss, E. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30899-3 · Cited by 45
for the Austrian Society of Gastroenterology and Hepatology (ÖGGH), Peck‐Radosavljevic, M., Angermayr, B., Datz, C., Ferlitsch, A., Ferlitsch, M., Fuhrmann, V., Häfner, M., Kramer, L., Maieron, A., et al. (2013) · Wiener klinische Wochenschrift · doi:10.1007/s00508-013-0337-z · Cited by 46
Pathophysiology of Hepatorenal Syndrome – Acute Kidney Injury
Adebayo, D., & Wong, F. S.-H. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.034 · Cited by 48
Prevention and Management of Bacterial Infections in Cirrhosis
Taneja, S., & Dhiman, R. K. (2011) · International Journal of Hepatology · doi:10.4061/2011/784540 · Cited by 45
Hepatorenal syndrome: Update on diagnosis and treatment
Baraldi, O., Valentini, C., Donati, G., Comai, G., Cuna, V., Capelli, I., Angelini, M. L., Moretti, M. I., Angeletti, A., Piscaglia, F., et al. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i5.511 · Cited by 45
Nanchal, R. S., & Ahmad, S. (2016) · Critical Care Clinics · doi:10.1016/j.ccc.2016.03.006 · Cited by 45
Cullaro, G., Park, M., & Lai, J. C. (2018) · Hepatology · doi:10.1002/hep.30058 · Cited by 45
Muñoz, S. J. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.03.007 · Cited by 45
Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
Farias, A. Q., Vilalta, A. C., Zitelli, P. M., Pereira, G., Gonçalves, L. L., Torre, A., Diaz, J. M., Gadano, A. C., de Mattos, Â. Z., Mendes, L. S. C., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.05.033 · Cited by 47
Self-citationOutcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis
Tonon, M., Piano, S. S., Gambino, C. G., Romano, A., Pilutti, C., Incicco, S., Brocca, A., Sticca, A., Bolognesi, M., & Angeli, P. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.03.065 · Cited by 44
Cohen, M. J., Sahar, T., Benenson, S., Elinav, E., Brezis, M., & Soares‐Weiser, K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004791.pub2 · Cited by 43
Translocación de productos de origen bacteriano en la cirrosis
Bellot, P., Francés, R., & Such, J. M. (2008) · Gastroenterología y Hepatología · doi:10.1157/13127094 · Cited by 43
Self-citationOptimal management of hepatorenal syndrome in patients with cirrhosis
Angeli, P. (2010) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s6918 · Cited by 42
Acute kidney injury in children with chronic liver disease
Deep, A., Saxena, R., & Jose, B. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3893-7 · Cited by 42
Bacterial infections in cirrhosis: A growing problem with significant implications
Fernández, J., & Arroyo, V. (2013) · Clinical Liver Disease · doi:10.1002/cld.169 · Cited by 41
Self-citationMedical management of hepatorenal syndrome
Davenport, A., Ahmad, J., Al-Khafaji, A. H., Kellum, J. A., Genyk, Y., & Nadim, M. K. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr736 · Cited by 41
Solà, E., Pose, E., Campion, D., Piano, S., Roux, O., Simon-Talero, M., Uschner, F., de Wit, K., Zaccherini, G., Alessandria, C., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.009 · Cited by 41
Self-citationHepatic encephalopathy in acute-on-chronic liver failure
Lee, G. H. (2015) · Hepatology International · doi:10.1007/s12072-015-9626-0 · Cited by 41
Metadata
- Authors
- Fernández, J., Navasa, M., Planas, R., Montoliu, S., Monfort, D., Soriano, G., Vila, C., Pardo, A., Quintero, E., Vargas, V., Such, J., Ginès, P., & Arroyo, V.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital de Sant Pau (ES)
- Hospital Del Mar (ES)
- Hospital Universitario de Canarias (ES)
- Corresponding author
- Navasa, Miquel
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 133
- Issue
- 3
- Pages
- 818-824
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2012746560
- Cited by
- 709
- References
- 36
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 23 · 2023: 37 · 2022: 28 · 2021: 43 · 2020: 39 · 2019: 42 · 2018: 42 · 2017: 37 · 2016: 34 · 2015: 55 · 2014: 48 · 2013: 31 · 2012: 46
- FWCI
- 30.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Keywords
- spontaneous bacterial peritonitis, primary prophylaxis, norfloxacin, hepatorenal syndrome, liver cirrhosis, survival, renal dysfunction, antibiotic prophylaxis
- MeSH terms
- Aged, Anti-Infective Agents, Double-Blind Method, Female, Hepatorenal Syndrome, Humans, Liver Cirrhosis, Male, Middle Aged, Norfloxacin, Peritonitis, Risk Factors, Survival Analysis, Antibiotic Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
